Interventional Cardiology Unit, Hospital Universitario HM Montepríncipe, HM Hospitales, Madrid, Spain; San Pablo CEU University, Madrid, Spain; Interventional Cardiology Unit, Hospital Universitario HLA Moncloa, Madrid, Spain.
Interventional Cardiology Unit, Hospital Universitario HM Montepríncipe, HM Hospitales, Madrid, Spain; Interventional Cardiology Unit, Hospital Universitario HLA Moncloa, Madrid, Spain.
Cardiovasc Revasc Med. 2021 Nov;32:69-74. doi: 10.1016/j.carrev.2021.01.005. Epub 2021 Jan 14.
Percutaneous intervention in the context of coronary artery ectasia (CAE) is penalized with no-reflow phenomenon. The glycoprotein-IIb/IIIa-inhibitor abciximab was the most accepted method for pharmacology thrombus resolution in this scenario, nevertheless, this agent was recently withdrawn. We describe 5 patients treated with local intracoronary fibrinolysis administrated through predesigned catheters in the setting of AMI and CAE.
经皮介入治疗在冠状动脉扩张（CAE）的情况下会受到无复流现象的影响。糖蛋白 IIb/IIIa 抑制剂阿昔单抗是这种情况下最被接受的血栓溶解药理学方法，但最近已被撤回。我们描述了 5 例 AMI 和 CAE 患者使用预先设计的导管进行局部冠状动脉内溶栓治疗的情况。
